Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma.

ABSTRACT: Major progress in the treatment of multiple myeloma has been made in the last several years. However, myeloma remains incurable and patients with high-risk cytogenetics or advanced stage disease have an even worsen survival. Only allogeneic transplantation may have curative potential in some patients. However, the high non-relapse mortality and incidence of chronic graft-versus-host disease have raised controversy regarding this procedure. In this review, we will address the role of upfront and delayed allogeneic transplant.

SUBMITTER: Claveau JS 

PROVIDER: S-EPMC9098709 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature